The most recent studies have indicated that the MET mutation was not only related to NSCLC but also contributed to the occurrence of pulmonary sarcomatoid carcinomas and lung adenocarcinomas [19, 20]. The gene discussed is MET; the disease is lung adenocarcinoma.